# Third of a series of letters regarding the implementation of the Act - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/industry-letter/third-of-a-series-of-letters-regarding-the-implementation-of-the-act/e65f7075-0b47-4965-97da-74fe25c9bbfd

> FDA guidance document: Third of a series of letters regarding the implementation of the Act. Issue date: March 02, 1998. Get complete insights and analysis.

---

## Details

- Title: Third of a series of letters regarding the implementation of the Act
- Communication Type: Industry Letter
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1998-03-02
- Last Changed: 2021-03-09
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0595">FDA-2011-D-0595</a>

## Related Documents

- [Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-the-human-pharmacokinetics-and-bioavailability-section-of-an-application/0fc0547b-5081-4033-af56-10b885a39a8f)
- [Review of FDA's Implementation of the Drug Export Amendments of 1986](https://www.globalkeysolutions.net/guidances/guidance-document/review-of-fdas-implementation-of-the-drug-export-amendments-of-1986/ac263315-7a67-481c-bd92-f824fd3c796a)
- [Study of Drugs Likely to be used in the Elderly](https://www.globalkeysolutions.net/guidances/guidance-document/study-of-drugs-likely-to-be-used-in-the-elderly/00cfcd92-8ac1-4307-968b-117b25f0493c)